 |
인쇄하기
취소
|
Daewha Pharm wins Korean patent for amodipine
Daewha Pharm announced in its regulatory filing on June 11 that it acquired a Korea patent for manufacturing film-coated granules containing amodipine or S-amlodipine salts and excipients.
S-amlodipine salts are said to be effective in the prevention and treatment of hypertension.
The firm is now undertaking bioequivalence testing using the above materials.
It will be possible to launc...
S-amlodipine salts are said to be effective in the prevention and treatment of hypertension.
The firm is now undertaking bioequivalence testing using the above materials.
It will be possible to launc...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.